Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-29

Clinical Trial Update: Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing remimazolam to dexmedetomidine for intraoperative sedation in orthopedic disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Remimazolam (remimazolam)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Orthopedic Disorder | Phase 4 | Status: COMPLETED